Global Bio-pharma Market Status and Outlook 2018-2025

July 2018 | 196 pages | ID: G237CFC355BEN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Pfizer
• F. Hoffmann-La Roche AG
• Johnson & Johnson Services
• Sanofi, Amgen
• AbbVie
• Merck & Co.
• Biogen Idec
• Bayer AG
• Eli Lilly and Company
• Novartis AG GlaxoSmithKline Plc
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories

Market by Type

• Monoclonal Antibodies
• Recombinant Proteins
• Granulocyte-Colony Stimulating Factor (G-CSF)
• Interferons
• Recombinant Human Insulin
• Erythropoietin
• Vaccines
• Growth Hormones
• Purified Proteins
• Others

Market by Application

• Metabolic Disorders
• Oncology
• Neurological Disorders
• Cardiovascular Diseases
• Inflammatory and Infectious Diseases
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Bio-pharma Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Monoclonal Antibodies
  3.1.2 Recombinant Proteins
  3.1.3 Granulocyte-Colony Stimulating Factor (G-CSF)
  3.1.4 Interferons
  3.1.5 Recombinant Human Insulin
  3.1.6 Erythropoietin
  3.1.7 Vaccines
  3.1.8 Growth Hormones
  3.1.9 Purified Proteins
  3.1.10 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Metabolic Disorders
  4.1.2 Oncology
  4.1.3 Neurological Disorders
  4.1.4 Cardiovascular Diseases
  4.1.5 Inflammatory and Infectious Diseases
  4.1.6 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Monoclonal Antibodies Production by Region
    6.1.1.2 Recombinant Proteins Production by Region
    6.1.1.3 Granulocyte-Colony Stimulating Factor (G-CSF) Production by Region
    6.1.1.4 Interferons Production by Region
    6.1.1.5 Recombinant Human Insulin Production by Region
    6.1.1.6 Erythropoietin Production by Region
    6.1.1.7 Vaccines Production by Region
    6.1.1.8 Growth Hormones Production by Region
    6.1.1.9 Purified Proteins Production by Region
    6.1.1.10 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Metabolic Disorders Production by Region
    6.1.2.2 Oncology Production by Region
    6.1.2.3 Neurological Disorders Production by Region
    6.1.2.4 Cardiovascular Diseases Production by Region
    6.1.2.5 Inflammatory and Infectious Diseases Production by Region
    6.1.2.6 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Monoclonal Antibodies Demand by Region
    6.2.1.2 Recombinant Proteins Demand by Region
    6.2.1.3 Granulocyte-Colony Stimulating Factor (G-CSF) Demand by Region
    6.2.1.4 Interferons Demand by Region
    6.2.1.5 Recombinant Human Insulin Demand by Region
    6.2.1.6 Erythropoietin Demand by Region
    6.2.1.7 Vaccines Demand by Region
    6.2.1.8 Growth Hormones Demand by Region
    6.2.1.9 Purified Proteins Demand by Region
    6.2.1.10 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Metabolic Disorders Demand by Region
    6.2.2.2 Oncology Demand by Region
    6.2.2.3 Neurological Disorders Demand by Region
    6.2.2.4 Cardiovascular Diseases Demand by Region
    6.2.2.5 Inflammatory and Infectious Diseases Demand by Region
    6.2.2.6 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Pfizer
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 F. Hoffmann-La Roche AG
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Johnson & Johnson Services
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Sanofi, Amgen
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 AbbVie
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Merck & Co.
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Biogen Idec
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Bayer AG
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Eli Lilly and Company
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Novartis AG GlaxoSmithKline Plc
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Bristol-Myers Squibb Company
8.12 AstraZeneca PLC
8.13 Abbott Laboratories

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Bio-pharma Industry Dynamics & Regulations List
Table Global Bio-pharma Sales Revenue, Cost and Margin, 2015-2018E
Table Global Bio-pharma Market Status by Type 2015-2018E, in USD Million
Table Global Bio-pharma Market Status by Application 2015-2018E, in USD Million
Table Global Bio-pharma Market Status by Application 2015-2018E, in Volume
Table Global Bio-pharma Market by Region 2015-2018E, in USD Million
Table Global Bio-pharma Market Share by Region in 2018, in USD Million
Table Global Bio-pharma Market by Region 2015-2018E, in Volume
Table Global Bio-pharma Market Share by Region in 2018, in Volume
Table Monoclonal Antibodies Production Value by Region 2015-2018E, in USD Million
Table Monoclonal Antibodies Production Volume by Region 2015-2018E, in Volume
Table Recombinant Proteins Production Value by Region 2015-2018E, in USD Million
Table Recombinant Proteins Production Volume by Region 2015-2018E, in Volume
Table Granulocyte-Colony Stimulating Factor (G-CSF) Production Value by Region 2015-2018E, in USD Million
Table Granulocyte-Colony Stimulating Factor (G-CSF) Production Volume by Region 2015-2018E, in Volume
Table Interferons Production Value by Region 2015-2018E, in USD Million
Table Interferons Production Volume by Region 2015-2018E, in Volume
Table Recombinant Human Insulin Production Value by Region 2015-2018E, in USD Million
Table Recombinant Human Insulin Production Volume by Region 2015-2018E, in Volume
Table Erythropoietin Production Value by Region 2015-2018E, in USD Million
Table Erythropoietin Production Volume by Region 2015-2018E, in Volume
Table Vaccines Production Value by Region 2015-2018E, in USD Million
Table Vaccines Production Volume by Region 2015-2018E, in Volume
Table Growth Hormones Production Value by Region 2015-2018E, in USD Million
Table Growth Hormones Production Volume by Region 2015-2018E, in Volume
Table Purified Proteins Production Value by Region 2015-2018E, in USD Million
Table Purified Proteins Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Metabolic Disorders Production Value by Region 2015-2018E, in USD Million
Table Metabolic Disorders Production Volume by Region 2015-2018E, in Volume
Table Oncology Production Value by Region 2015-2018E, in USD Million
Table Oncology Production Volume by Region 2015-2018E, in Volume
Table Neurological Disorders Production Value by Region 2015-2018E, in USD Million
Table Neurological Disorders Production Volume by Region 2015-2018E, in Volume
Table Cardiovascular Diseases Production Value by Region 2015-2018E, in USD Million
Table Cardiovascular Diseases Production Volume by Region 2015-2018E, in Volume
Table Inflammatory and Infectious Diseases Production Value by Region 2015-2018E, in USD Million
Table Inflammatory and Infectious Diseases Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Monoclonal Antibodies Market Size by Region 2015-2018E, in USD Million
Table Monoclonal Antibodies Market Size by Region 2015-2018E, in Volume
Table Recombinant Proteins Market Size by Region 2015-2018E, in USD Million
Table Recombinant Proteins Market Size by Region 2015-2018E, in Volume
Table Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Region 2015-2018E, in USD Million
Table Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Region 2015-2018E, in Volume
Table Interferons Market Size by Region 2015-2018E, in USD Million
Table Interferons Market Size by Region 2015-2018E, in Volume
Table Recombinant Human Insulin Market Size by Region 2015-2018E, in USD Million
Table Recombinant Human Insulin Market Size by Region 2015-2018E, in Volume
Table Erythropoietin Market Size by Region 2015-2018E, in USD Million
Table Erythropoietin Market Size by Region 2015-2018E, in Volume
Table Vaccines Market Size by Region 2015-2018E, in USD Million
Table Vaccines Market Size by Region 2015-2018E, in Volume
Table Growth Hormones Market Size by Region 2015-2018E, in USD Million
Table Growth Hormones Market Size by Region 2015-2018E, in Volume
Table Purified Proteins Market Size by Region 2015-2018E, in USD Million
Table Purified Proteins Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Metabolic Disorders Market Size by Region 2015-2018E, in USD Million
Table Metabolic Disorders Market Size by Region 2015-2018E, in Volume
Table Oncology Market Size by Region 2015-2018E, in USD Million
Table Oncology Market Size by Region 2015-2018E, in Volume
Table Neurological Disorders Market Size by Region 2015-2018E, in USD Million
Table Neurological Disorders Market Size by Region 2015-2018E, in Volume
Table Cardiovascular Diseases Market Size by Region 2015-2018E, in USD Million
Table Cardiovascular Diseases Market Size by Region 2015-2018E, in Volume
Table Inflammatory and Infectious Diseases Market Size by Region 2015-2018E, in USD Million
Table Inflammatory and Infectious Diseases Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalBio-pharma Forecast by Type 2019F-2025F, in USD Million
Table Bio-pharma Forecast by Type 2019F-2025F, in Volume
Table Bio-pharma Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Bio-pharma Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Bio-pharma Market Forecast by Region 2019F-2025F, in USD Million
Table Bio-pharma Market Forecast by Region 2019F-2025F, in Volume
Table Pfizer Information
Table Bio-pharma Sales, Cost, Margin of Pfizer
Table F. Hoffmann-La Roche AG Information
Table Bio-pharma Sales, Cost, Margin of F. Hoffmann-La Roche AG
Table Johnson & Johnson Services Information
Table Bio-pharma Sales, Cost, Margin of Johnson & Johnson Services
Table Sanofi, Amgen Information
Table Bio-pharma Sales, Cost, Margin of Sanofi, Amgen
Table AbbVie Information
Table Bio-pharma Sales, Cost, Margin of AbbVie
Table Merck & Co. Information
Table Bio-pharma Sales, Cost, Margin of Merck & Co.
Table Biogen Idec Information
Table Bio-pharma Sales, Cost, Margin of Biogen Idec
Table Bayer AG Information
Table Bio-pharma Sales, Cost, Margin of Bayer AG
Table Eli Lilly and Company Information
Table Bio-pharma Sales, Cost, Margin of Eli Lilly and Company
Table Novartis AG GlaxoSmithKline Plc Information
Table Bio-pharma Sales, Cost, Margin of Novartis AG GlaxoSmithKline Plc
Table Bristol-Myers Squibb Company Information
Table Bio-pharma Sales, Cost, Margin of Bristol-Myers Squibb Company
Table AstraZeneca PLC Information
Table Bio-pharma Sales, Cost, Margin of AstraZeneca PLC
Table Abbott Laboratories Information
Table Bio-pharma Sales, Cost, Margin of Abbott Laboratories
Table Global Bio-pharma Sales Revenue by Company 2015-2017, in USD Million
Table Global Bio-pharma Sales Volume by Company 2015-2017, in Volume
Table Global Bio-pharma Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Bio-pharma Picture
Figure Bio-pharma Industry Chain Diagram
Figure Global Bio-pharma Sales Revenue 2015-2018E, in USD Million
Figure Global Bio-pharma Sales Volume 2015-2018E, in Volume
Figure Global Bio-pharma Market Status by Type 2015-2018E, in Volume
Figure North America Bio-pharma Market Size and Growth 2015-2018E, in USD Million
Figure North America Bio-pharma Market Size and Growth 2015-2018E, in Volume
Figure Europe Bio-pharma Market Size and Growth 2015-2018E, in USD Million
Figure Europe Bio-pharma Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Bio-pharma Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Bio-pharma Market Size and Growth 2015-2018E, in Volume
Figure South America Bio-pharma Market Size and Growth 2015-2018E, in USD Million
Figure South America Bio-pharma Market Size and Growth 2015-2018E, in Volume
Figure Middle East Bio-pharma Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Bio-pharma Market Size and Growth 2015-2018E, in Volume
Figure Africa Bio-pharma Market Size and Growth 2015-2018E, in USD Million
Figure Africa Bio-pharma Market Size and Growth 2015-2018E, in Volume
Figure Global Bio-pharma Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Bio-pharma Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Bio-pharma Sales Price Forecast 2019F-2025F
Figure Global Bio-pharma Gross Margin Forecast 2019F-2025F
Figure Global Bio-pharma Sales Revenue by Company in 2018, in USD Million
Figure Global Bio-pharma Price by Company in 2018
Figure Global Bio-pharma Gross Margin by Company in 2018